Smith & Nephew slips after Q1 growth narrowly misses, despite new $500M buyback
Smith & Nephew shares fell after its Q1 2026 trading update showed 3.1% underlying revenue growth to $1.501 billion, slightly below market expectations. The company reiterated full-year guidance and announced a new $500 million share buyback, but investors focused on softer-than-expected growth and U.S. knee implant weakness.
1. What’s driving SNN lower today
Smith & Nephew (SNN) is trading lower after releasing its first-quarter 2026 trading update on May 6, 2026. The company reported Q1 revenue of $1.501 billion with underlying revenue growth of 3.1%, a touch below consensus expectations, keeping the focus on whether growth is tracking fast enough into the rest of 2026. (borsaitaliana.it)
2. Key numbers and guidance headline
The company reiterated its full-year 2026 outlook, signaling management still expects the year’s performance to build as 2026 progresses. Even with the reaffirmed outlook, the modest top-line miss is weighing on the stock given heightened sensitivity to quarterly cadence. (uk.marketscreener.com)
3. Capital return didn’t offset the growth concern
Smith & Nephew also announced a new $500 million share buyback program to be completed within the next 12 months. While buybacks typically provide support, the market reaction suggests investors were more concerned about the underlying growth trajectory—particularly commentary around U.S. knee implant sales—than incremental capital return. (uk.marketscreener.com)